Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2011, Article ID 650685, 7 pages
http://dx.doi.org/10.4061/2011/650685
Review Article

Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment

1Anatomy Section, Department of Integrative Medical Biology, Umeå University, 901 87 Umeå, Sweden
2Department of Medicine, Rheumatology and Inflammation Research Unit, University of Gothenburg, 405 30 Gothenburg, Sweden
3Department of Surgery and Perioperative Sciences, Orthopaedics, Umeå University, 901 85 Umeå, Sweden
4Department of Public Health and Clinical Medicine, Rheumatology, Umeå University, 901 85 Umeå, Sweden

Received 12 March 2011; Accepted 19 April 2011

Academic Editor: Norbert Leitinger

Copyright © 2011 Sture Forsgren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Grimsholm, S. Rantapää-Dahlqvist, T. Dalén, and S. Forsgren, “BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters,” Clinical Rheumatology, vol. 27, no. 10, pp. 1289–1297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Korsching, “The neurotrophic factor concept: a reexamination,” Journal of Neuroscience, vol. 13, no. 7, pp. 2739–2748, 1993. View at Google Scholar · View at Scopus
  3. D. Johnson, A. Lanahan, and C. R. Buck, “Expression and structure of the human NGF receptor,” Cell, vol. 47, pp. 545–554, 1986. View at Google Scholar
  4. D. Martin-Zanca, R. Oskam, G. Mitra, T. Copeland, and M. Barbacid, “Molecular and biochemical characterization of the human trk proto-oncogene,” Molecular and Cellular Biology, vol. 9, no. 1, pp. 24–33, 1989. View at Google Scholar · View at Scopus
  5. B. S. Chapman and I. D. Kuntz, “Modeled structure of the 75-kDa neurotrophin receptor,” Protein Science, vol. 4, no. 9, pp. 1696–1707, 1995. View at Google Scholar · View at Scopus
  6. W. A. Nockher and H. Renz, “Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation,” Clinica Chimica Acta, vol. 352, no. 1-2, pp. 49–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Bagge, R. Lorentzon, H. Alfredson, and S. Forsgren, “Unexpected presence of the neurotrophins NGF and BDNF and the neurotrophin receptor p75 in the tendon cells of the human Achilles tendon,” Histology and Histopathology, vol. 24, no. 7, pp. 839–848, 2009. View at Google Scholar · View at Scopus
  8. R. Levi-Montalcini, L. Aloe, and E. Alleva, “A role for nerve growth factor in nervous, endocrine and immune systems,” Progress in Neuroendocrinoimmunology, vol. 3, pp. 1–10, 1990. View at Google Scholar
  9. S. Linnarsson, C. A. Willson, and P. Ernfors, “Cell death in regenerating populations of neurons in BDNF mutant mice,” Molecular Brain Research, vol. 75, no. 1, pp. 61–69, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Tessarollo, “Pleiotropic functions of neurotrophins in development,” Cytokine and Growth Factor Reviews, vol. 9, no. 2, pp. 125–137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Gillardon, C. Eschenfelder, R. A. Rush, and M. Zimmerman, “Increase in neuronal Jun immunoreactivity and epidermal NGF levels following UV exposure of rat skin,” NeuroReport, vol. 6, no. 9, pp. 1322–1324, 1995. View at Google Scholar · View at Scopus
  12. A. Markus, T. D. Patel, and W. D. Snider, “Neurotrophic factors and axonal growth,” Current Opinion in Neurobiology, vol. 12, no. 5, pp. 523–531, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Tortorolo, A. Langer, G. Polidori et al., “Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 2, pp. 233–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Johansson, O. Norrgard, and S. Forsgren, “Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 13, no. 4, pp. 398–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Persson-Sjogren, D. Holmberg, and S. Forsgren, “Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse,” Journal of Neuroimmunology, vol. 158, no. 1-2, pp. 128–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kerschensteiner, E. Gallmeier, L. Behrens et al., “Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?” Journal of Experimental Medicine, vol. 189, no. 5, pp. 865–870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Reinshagen, H. Rohm, M. Steinkamp et al., “Protective role of neurotrophins in experimental inflammation of the rat gut,” Gastroenterology, vol. 119, no. 2, pp. 368–376, 2000. View at Google Scholar · View at Scopus
  18. L. Manni, T. Lundeberg, P. Tirassa, and L. Aloe, “Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats,” Rheumatology, vol. 41, no. 7, pp. 787–792, 2002. View at Google Scholar · View at Scopus
  19. Z. Zhu, H. Friess, X. Shi et al., “Up-regulation of p75 neurotrophin receptor (p75NTR) is associated with apoptosis in chronic pancreatitis,” Digestive Diseases and Sciences, vol. 48, no. 4, pp. 717–725, 2003. View at Publisher · View at Google Scholar
  20. A. Merighi, C. Salio, A. Ghirri et al., “BDNF as a pain modulator,” Progress in Neurobiology, vol. 85, no. 3, pp. 297–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Lamb, G. F. Gebhart, and K. Bielefeldt, “Increased nerve growth factor expression triggers bladder overactivity,” Journal of Pain, vol. 5, no. 3, pp. 150–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. L. H. Bennett, “Neurotrophic factors: important regulators of nociceptive function,” Neuroscientist, vol. 7, no. 1, pp. 13–17, 2001. View at Google Scholar · View at Scopus
  23. S. M. Garraway, J. C. Petruska, and L. M. Mendell, “BDNF sensitizes the response of lamina II neurons to high threshold primary afferent inputs,” European Journal of Neuroscience, vol. 18, no. 9, pp. 2467–2476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Behnia, L. Zhang, M. Charles, and M. S. Gold, “Changes in TrkB-like immunoreactivity in rat trigeminal ganglion after tooth injury,” Journal of Endodontics, vol. 29, no. 2, pp. 135–140, 2003. View at Publisher · View at Google Scholar
  25. L. Aloe, M. A. Tuveri, U. Carcassi, and R. Levi-Montalcini, “Nerve growth factor in the synovial fluid of patients with chronic arthritis,” Arthritis and Rheumatism, vol. 35, no. 3, pp. 351–355, 1992. View at Google Scholar · View at Scopus
  26. L. Aloe, “Nerve growth factor, human skin ulcers and vascularization. Our experience,” Progress in Brain Research, vol. 146, pp. 515–522, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Halliday, C. Zettler, R. A. Rush, R. Scicchitano, and J. D. McNeil, “Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease,” Neurochemical Research, vol. 23, no. 6, pp. 919–922, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Dicou, C. Masson, W. Jabbour, and V. Nerriere, “Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients,” NeuroReport, vol. 5, no. 3, pp. 321–324, 1993. View at Google Scholar · View at Scopus
  29. F. Falcini, M. Matucci Cerinic, A. Lombardi et al., “Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis,” Annals of the Rheumatic Diseases, vol. 55, no. 10, pp. 745–748, 1996. View at Google Scholar · View at Scopus
  30. Z. Wu, K. Nagata, and T. Iijima, “Immunohistochemical study of NGF and its receptors in the synovial membrane of the ankle joint of adjuvant-induced arthritic rats,” Histochemistry and Cell Biology, vol. 114, no. 6, pp. 453–459, 2000. View at Google Scholar · View at Scopus
  31. M. Rihl, E. Kruithof, C. Barthel et al., “Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment,” Annals of the Rheumatic Diseases, vol. 64, no. 11, pp. 1542–1549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Weidler, C. Holzer, M. Harbux et al., “Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium,” Annals of the Rheumatic Diseases, vol. 64, no. 1, pp. 13–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Li, Y. Guo, R. Holmdahl, and T. Ny, “Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2541–2548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Grimsholm, Y. Guo, T. Ny, and S. Forsgren, “Expression patterns of neurotrophins and neurotrophin receptors in articular chondrocytes and inflammatory infiltrates in knee joint arthritis,” Cells Tissues Organs, vol. 188, no. 3, pp. 299–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Gigante, C. Bevilacqua, A. Pagnotta, S. Manzotti, A. Toesca, and F. Greco, “Expression of NGF, Trka and p75 in human cartilage,” European Journal of Histochemistry, vol. 47, no. 4, pp. 339–344, 2003. View at Google Scholar · View at Scopus
  36. F. Iannone, C. De Bari, F. Dell'Accio et al., “Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes,” Rheumatology, vol. 41, no. 12, pp. 1413–1418, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Laske, E. Stransky, G. W. Eschweiler et al., “Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants,” Journal of Psychiatric Research, vol. 41, no. 7, pp. 600–605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Haas, L. V. C. Portela, A. E. Böhmer, J. P. Oses, and D. R. Lara, “Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia,” Neurochemical Research, vol. 35, no. 5, pp. 830–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Raap, C. Goltz, N. Deneka et al., “Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1268–1275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. T. A. Tanure, R. S. Gomez, R. C. L. Hurtado, A. L. Teixeira, and R. B. Domingues, “Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study,” Journal of Headache and Pain, vol. 11, no. 5, pp. 427–430, 2010. View at Google Scholar
  41. S. Yoshimura, H. Ochi, N. Isobe et al., “Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 10, pp. 1178–1188, 2010. View at Publisher · View at Google Scholar
  42. A. Ghaffariyeh, N. Honarpisheh, M. H. Heidari, S. Puyan, and F. Abasov, “Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma,” Optometry and Vision Science, vol. 88, no. 1, pp. 80–85, 2011. View at Publisher · View at Google Scholar
  43. K. Hashimoto, “Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions,” Psychiatry and Clinical Neurosciences, vol. 64, no. 4, pp. 341–357, 2010. View at Publisher · View at Google Scholar
  44. L. Bocchio-Chiavetto, V. Bagnardi, R. Zanardini et al., “Serum and plasma BDNF levels in major depression: a replication study and meta-analyses,” World Journal of Biological Psychiatry, vol. 11, no. 6, pp. 763–773, 2010. View at Publisher · View at Google Scholar
  45. Y. Shi, J. You, Y. Yuan, X. Zhang, H. Li, and G. Hou, “Plasma BDNF and tPA are associated with late-onset geriatric depression,” Psychiatry and Clinical Neurosciences, vol. 64, no. 3, pp. 249–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Pedrini, I. Chendo, I. Grande et al., “Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation,” Neuroscience Letters, vol. 491, no. 3, pp. 207–210, 2011. View at Publisher · View at Google Scholar
  47. W. C. Lafrance Jr., K. Leaver, E. G. Stopa, G. D. Papandonatos, and A. S. Blum, “Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures,” Neurology, vol. 75, no. 14, pp. 1285–1291, 2010. View at Publisher · View at Google Scholar
  48. L. Dell'osso, A. Del Debbio, A. Veltri et al., “Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients,” Neuropsychobiology, vol. 62, no. 4, pp. 207–212, 2010. View at Publisher · View at Google Scholar
  49. A. González-Pinto, F. Mosquera, A. Palomino et al., “Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics,” International Clinical Psychopharmacology, vol. 25, no. 4, pp. 241–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Ikenouchi-Sugita, R. Yoshimura, T. Okamoto et al., “Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus,” World Journal of Biological Psychiatry, vol. 11, no. 2, pp. 121–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Namura, G. Hasegawa, M. Egawa et al., “Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis,” Clinical Immunology, vol. 122, no. 2, pp. 181–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. G. C. Müller, P. M. Pitrez, A. L. Teixeira et al., “Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma,” Clinical and Experimental Allergy, vol. 40, no. 12, pp. 1755–1759, 2010. View at Publisher · View at Google Scholar
  53. E. Golden, A. Emiliano, S. Maudsley et al., “Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the baltimore longitudinal study of aging,” PLoS ONE, vol. 5, no. 4, article 010099, 2010. View at Publisher · View at Google Scholar
  54. J. Currie, R. Ramsbottom, H. Ludlow, A. Nevill, and M. Gilder, “Cardio-respiratory fitness, habitual physical activity and serum brain derived neurotrophic factor (BDNF) in men and women,” Neuroscience Letters, vol. 451, no. 2, pp. 152–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Levinger, C. Goodman, V. Matthews et al., “BDNF, metabolic risk factors, and resistance training in middle-aged individuals,” Medicine and Science in Sports and Exercise, vol. 40, no. 3, pp. 535–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. A. Zoladz and A. Pilc, “The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies,” Journal of Physiology and Pharmacology, vol. 61, no. 5, pp. 533–541, 2010. View at Google Scholar
  57. K. Knaepen, M. Goekint, E. M. Heyman, and R. Meeusen, “Neuroplasticity exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects,” Sports Medicine, vol. 40, no. 9, pp. 765–801, 2010. View at Publisher · View at Google Scholar
  58. J. F. Yarrow, L. J. White, S. C. McCoy, and S. E. Borst, “Training augments resistance exercise induced elevation of circulating brain derived neurotrophic factor (BDNF),” Neuroscience Letters, vol. 479, no. 2, pp. 161–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Laske, S. Banschbach, E. Stransky et al., “Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression,” International Journal of Neuropsychopharmacology, vol. 13, no. 5, pp. 595–602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Y. Wu, T. F. Wang, L. Yu et al., “Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway,” Brain, Behavior, and Immunity, vol. 25, no. 1, pp. 135–146, 2011. View at Publisher · View at Google Scholar
  61. YU. Nofuji, M. Suwa, Y. Moriyama et al., “Decreased serum brain-derived neurotrophic factor in trained men,” Neuroscience Letters, vol. 437, no. 1, pp. 29–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. A. B. Klein, R. Williamson, M. A. Santini et al., “Blood BDNF concentrations reflect brain-tissue BDNF levels across species,” International Journal of Neuropsychopharmacology, vol. 14, pp. 347–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Seifert, P. Brassard, M. Wissenberg et al., “Endurance training enhances BDNF release from the human brain,” American Journal of Physiology, vol. 298, no. 2, pp. R372–R377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Sartorius, R. Hellweg, J. Litzke et al., “Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats,” Pharmacopsychiatry, vol. 42, no. 6, pp. 270–276, 2009. View at Publisher · View at Google Scholar
  65. P. Rasmussen, P. Brassard, H. Adser et al., “Evidence for a release of brain-derived neurotrophic factor from the brain during exercise,” Experimental Physiology, vol. 94, no. 10, pp. 1062–1069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. F. del Porto, L. Aloe, B. Laganà, V. Triaca, I. Nofroni, and R. D'Amelio, “Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-α blockers,” Annals of the New York Academy of Sciences, vol. 1069, pp. 438–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. O. Schulte-Herbrüggen, C. Nassenstein, M. Lommatzsch, D. Quarcoo, H. Renz, and A. Braun, “Tumor necrosis factor-α and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes,” Journal of Neuroimmunology, vol. 160, no. 1-2, pp. 204–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Murata, K. Olmarker, I. Takahashi, K. Takahashi, and B. Rydevik, “Effects of selective tumor necrosis factor-alpha inhibition to pain-behavioral changes caused by nucleus pulposus-induced damage to the spinal nerve in rats,” Neuroscience Letters, vol. 382, no. 1-2, pp. 148–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Onda, Y. Murata, B. Rydevik, K. Larsson, S. Kikuchi, and K. Olmarker, “Infliximab attenuates immunoreactivity of brain-derived neurotrophic factor in a rat model of herniated nucleus pulposus,” Spine, vol. 29, no. 17, pp. 1857–1861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Hess, R. Axmann, J. Rech et al., “From the covere: blockade of TNF-alpha; rapidly inhibits pain response in the central nervous system,” Proceedings of the Academy of Sciences USA, vol. 108, pp. 3731–3736, 2011. View at Google Scholar